It requires a systemic perspective where the parts are communicating vessels regardless of whether they are state, regional or private organized and funded. These include public authorities, academia, healthcare, clinical research providers and pharmaceutical and medical device companies.
“Administrative structures have the ability to counteract the political ambitions they are designed to address. It is a stated ambition that Sweden should be a prominent life science nation and that the number of clinical trials should increase. Regulators are an important piece of the puzzle and need to be attractive both in terms of fast and smooth processes and a reasonable and competitive price tag. Otherwise, the political system risks biting its own objectives in the tail.”
Frida Lawenius, Deputy CEO SwedenBIO
